COPIOS PEICARDIUM MEMBRANE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2017-04-07 for COPIOS PEICARDIUM MEMBRANE manufactured by Tutogen Medical Gmbh.

Event Text Entries

[72092483] Method: rti/tmi conducted a re-review of the product history record for copios pericardium membranes, packaging production records, environmental monitoring, product specification, distribution database for related complaints associated to the lot. Results: no departures from rti/tmi's procedures were noted during the manufacturing records re-review that negatively impacted copios pericardium membrane tissues from the lot. The xenograft underwent a validated sterilization methodology; tutoplast? , which includes terminal sterilization by gamma irradiation after final packaging. Rti/tmi has manufactured and distributed 100 copios pericardium membranes from lot# nz14510255 without related complaints. Environmental monitoring data generated during and around the time of processing were acceptable. According to records re-review serial id (b)(4) met rti/tmis specifications and release criteria prior to distribution. Conclusion: given the facts that (1) the xenograft underwent a validated sterilization methodology; tutoplast? ,which includes terminal sterilization by gamma irradiation after final packaging; (2) serial id (b)(4) met rti/tmi's specifications and release criteria prior to distribution; (3) environmental monitoring data was acceptable; (4) there are no related complaints associated with xenografts distributed from the lot; and (5) many factors may contribute to non-union/non-integration of the xenograft post-operatively. Examples include the physical location of the osteotomy or surgical site, placement of the allograft at the time of the surgical procedure, adjunct hardware or implants, relative movement of the implant within surrounding tissue, or non-compliance with therapy, therefore it is more plausible the patient's post-operative outcome was associated with a source or event extrinsic to the xenograft implant. Explanted and not available.
Patient Sequence No: 1, Text Type: N, H10


[72092484] The copios cancellous particles xenografts and copios pericardium membrane were implanted on (b)(6) 2016 in a female patient and it was reported there were no in growth.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3002924436-2017-00004
MDR Report Key6471593
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2017-04-07
Date of Report2017-04-07
Date of Event2016-04-08
Date Mfgr Received2017-03-22
Device Manufacturer Date2015-09-30
Date Added to Maude2017-04-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationDENTIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS CHARITY EMMONS
Manufacturer Street11621 RESEARCH CIRCLE
Manufacturer CityALACHUA FL 32615
Manufacturer CountryUS
Manufacturer Postal32615
Manufacturer Phone3864188888
Manufacturer G1RTI SURGICAL INC,
Manufacturer Street11621 RESEARCH CIRCLE
Manufacturer CityALACHUA FL 32615
Manufacturer CountryUS
Manufacturer Postal Code32615
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOPIOS PEICARDIUM MEMBRANE
Generic NamePEICARDIUM MEMBRANE
Product CodeNPL
Date Received2017-04-07
Lot NumberNZ14510255
OperatorDENTIST
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerTUTOGEN MEDICAL GMBH
Manufacturer AddressINDUSTRIERSTR 6 NEUNKIRCHEN AM BRAND, GERMANY 91077GM GM 91077 GM


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-04-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.